|Bid||271.13 x 800|
|Ask||271.16 x 1100|
|Day's Range||270.93 - 276.87|
|52 Week Range||192.79 - 309.60|
|Beta (5Y Monthly)||1.05|
|PE Ratio (TTM)||10.10|
|Earnings Date||Oct 25, 2021 - Oct 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar 29, 1994|
|1y Target Est||327.86|
Quest Diagnostics (DGX) is hopeful about the fact that COVID-19 testing remains critical as employees are returning to the workplace and students to the classroom.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
An RTP-based pharmaceutical firm is partnering with global life sciences company Labcorp to develop and commercialize RNA-based oncology diagnostics.